Citi Sticks to Its Sell Rating for Baxter International (BAX)
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Raises Target Price to $24
Evercore ISI Adjusts Price Target on Baxter International to $24 From $22
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24
Baxter International (BAX) Gets a Hold From Bank of America Securities
Citi Downgrades Baxter International Inc(BAX.US) to Sell Rating, Cuts Target Price to $17
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Astrana Health (ASTH) and Baxter International (BAX)
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $20
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $24
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH), Baxter International (BAX) and Cigna (CI)
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Capricor Therapeutics (CAPR)
Barclays Maintains Baxter International Inc(BAX.US) With Buy Rating, Maintains Target Price $27
Baxter International (BAX) Receives a Hold From Stifel Nicolaus
Analysts Are Bullish on Top Healthcare Stocks: Alkermes (ALKS), Baxter International (BAX)
Stifel Nicolaus Adjusts Baxter International Price Target to $19 From $20
Barclays Adjusts Baxter International Price Target to $27 From $25
Goldman Sachs Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $19
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Raises Target Price to $20
Research Alert: Bax Q1: Mixed Results Amid Operational Challenges And Transformation Efforts
TD Cowen Maintains Baxter International Inc(BAX.US) With Hold Rating, Cuts Target Price to $18.49